Cipla Ltd.

Cipla’s wholly owned subsidiary - Cipla (EU), UK, has entered into a definitive agreement for acquisition of 100% stake in Duomed Produtos Farmaceuticos (Duomed), a limited liability Company in Brazil for a cash consideration of Brazilian Real 1,293,600 approximately Rs 2.6 crore.

Duomed was incorporated on June 10, 2013. It has in place approval of ANVISA (Brazilian health authority) and other regulatory authorities to import and distribute pharmaceutical products in Brazil. The acquisition is part of company’s front-end strategy and will expedite its product registrations in Brazil. The transaction is expected to be completed by end of May 2015, subject to certain closing deliverables.

Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 170 countries. Its portfolio includes 2000 products in 65 therapeutic categories with one quality standard globally.